BUE Equity Snapshot

ABBV Weekly Equity Report

AbbVie Inc.

Interactive chart JSON snapshot
Latest Close 34,120 ARS 12 Jun 2026
1W Return -0.6% latest completed week
4W Return 8.7% short-term follow-through
12W Return 13.5% quarterly tape
Trend Breadth 61.5% 32 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
Company Brief

What the company does

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma …

Snapshot

What the weekly tape is saying

ABBV closed the latest completed week at 34,120 ARS. The 4-week return is 8.7% and the 12-week return is 13.5%. Trend Signal is inactive, Market Dynamics is 0.39. Setup signature: Balanced read with a 48/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 3.8%
Volume 1.1x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 34 Persistence of active Trend Signal over the last year and current streak.
Momentum 82 Blend of 4-week and 12-week follow-through.
Dynamics 68 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 45 Participation compared with the 13-week volume baseline.
Risk Control 57 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
32,876 ARS
Vs Trend Line
3.8%
Fair Value
21,777 ARS
Vs Fair Value
56.7%
52W High
38,539 ARS
52W Low
20,200 ARS
Drawdown
-11.5%
Range Position
75.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.6%
4W 8.7%
12W 13.5%
26W 1.7%
52W 50.0%

Trend read

Active Streak
0 weeks
52W Active Weeks
32
52W Active Breadth
61.5%
Sector Scope
AR Healthcare
Sector Rank
11 of 20
Sector Percentile
47.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.39
4W MD Change
134.7%
Relative Strength
-18.01
4W RS Change
-191.0%
Expectation
Undecided
Probability
45.04%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
7.7K
13W Average
7.1K
52W Average
6.8K
Vs 13W
1.1x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.3%
52W Volatility
4.5%
Upside Weeks
30
Downside Weeks
22
Downside Breadth
42.3%
Avg Gain / Loss
4.1% / -3.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
56007.3B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 34,120 ARS -0.6% 32,876 ARS 21,777 ARS 0.39 -18.01 7.7K Off
5 Jun 2026 34,340 ARS 6.2% 32,902 ARS 21,584 ARS -0.05 -10.38 8.8K Off
29 May 2026 32,340 ARS 0.4% 32,837 ARS 21,390 ARS -0.63 -17.71 5.2K Off
22 May 2026 32,200 ARS 2.5% 32,857 ARS 21,208 ARS -0.86 -8.79 10.2K Off
15 May 2026 31,400 ARS 4.9% 32,972 ARS 21,028 ARS -1.14 -6.19 5.8K Off
8 May 2026 29,920 ARS -6.0% 33,103 ARS 20,852 ARS -1.21 -12.28 5.3K Off
1 May 2026 31,840 ARS 7.1% 33,240 ARS 20,687 ARS -1.15 -8.64 6.4K Off
24 Apr 2026 29,720 ARS -2.3% 33,368 ARS 20,508 ARS -1.24 -14.94 6.9K Off
17 Apr 2026 30,420 ARS -0.9% 33,457 ARS 20,344 ARS -1.29 -14.34 8.3K Off
10 Apr 2026 30,700 ARS -4.1% 33,602 ARS 20,175 ARS -1.28 -16.54 12.4K Off
3 Apr 2026 32,000 ARS 3.4% 33,653 ARS 20,004 ARS -1.35 -13.05 2.8K Off
27 Mar 2026 30,960 ARS 3.0% 33,566 ARS 19,825 ARS -1.17 -9.86 3.9K Off
20 Mar 2026 30,060 ARS -6.8% 33,483 ARS 19,652 ARS -1.06 -10.31 9.0K Off
13 Mar 2026 32,260 ARS -5.4% 33,411 ARS 19,485 ARS -1.06 -0.74 4.0K Off